These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29229294)

  • 1. Impact of DHA intake in a mouse model of synucleinopathy.
    Coulombe K; Kerdiles O; Tremblay C; Emond V; Lebel M; Boulianne AS; Plourde M; Cicchetti F; Calon F
    Exp Neurol; 2018 Mar; 301(Pt A):39-49. PubMed ID: 29229294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Docosahexaenoic Acid (DHA) at the Enteric Level in a Synucleinopathy Mouse Model.
    Lamontagne-Proulx J; Coulombe K; Dahhani F; Côté M; Guyaz C; Tremblay C; Di Marzo V; Flamand N; Calon F; Soulet D
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice.
    Szego ÉM; Gerhardt E; Kermer P; Schulz JB
    Neurobiol Dis; 2012 Jan; 45(1):591-600. PubMed ID: 22001606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dietary n-3 polyunsaturated fatty acids on cognition, motor skills and hippocampal neurogenesis in developing C57BL/6J mice.
    Janssen CI; Zerbi V; Mutsaers MP; de Jong BS; Wiesmann M; Arnoldussen IA; Geenen B; Heerschap A; Muskiet FA; Jouni ZE; van Tol EA; Gross G; Homberg JR; Berg BM; Kiliaan AJ
    J Nutr Biochem; 2015 Jan; 26(1):24-35. PubMed ID: 25444517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein.
    Wang L; Fleming SM; Chesselet MF; Taché Y
    Neuroreport; 2008 May; 19(8):873-6. PubMed ID: 18463504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology.
    Ikeda M; Kawarabayashi T; Harigaya Y; Sasaki A; Yamada S; Matsubara E; Murakami T; Tanaka Y; Kurata T; Wuhua X; Ueda K; Kuribara H; Ikarashi Y; Nakazato Y; Okamoto K; Abe K; Shoji M
    Brain Res; 2009 Jan; 1250():232-41. PubMed ID: 18992718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary fish oil n-3 polyunsaturated fatty acids and alpha-linolenic acid differently affect brain accretion of docosahexaenoic acid and expression of desaturases and sterol regulatory element-binding protein 1 in mice.
    Zhu H; Fan C; Xu F; Tian C; Zhang F; Qi K
    J Nutr Biochem; 2010 Oct; 21(10):954-60. PubMed ID: 19954955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction.
    Gentzel RC; Toolan D; Jinn S; Schachter JB; Ma L; Kahle PJ; Smith SM; Marcus JN
    Neurobiol Aging; 2021 Oct; 106():12-25. PubMed ID: 34225000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex and Age Differences in a Progressive Synucleinopathy Mouse Model.
    Lamontagne-Proulx J; Coulombe K; Morissette M; Rieux M; Calon F; Di Paolo T; Soulet D
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice.
    Freichel C; Neumann M; Ballard T; Müller V; Woolley M; Ozmen L; Borroni E; Kretzschmar HA; Haass C; Spooren W; Kahle PJ
    Neurobiol Aging; 2007 Sep; 28(9):1421-35. PubMed ID: 16872721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Synucleinopathy models and human neuropathology: similarities and differences.
    Kahle PJ
    Acta Neuropathol; 2008 Jan; 115(1):87-95. PubMed ID: 17932682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy.
    Shukla JJ; Stefanova N; Bush AI; McColl G; Finkelstein DI; McAllum EJ
    Neurobiol Dis; 2021 Nov; 159():105509. PubMed ID: 34537326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system.
    Coulombe K; Saint-Pierre M; Cisbani G; St-Amour I; Gibrat C; Giguère-Rancourt A; Calon F; Cicchetti F
    J Nutr Biochem; 2016 Apr; 30():133-42. PubMed ID: 27012630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
    Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
    Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral Deficits and Brain α-Synuclein and Phosphorylated Serine-129 α-Synuclein in Male and Female Mice Overexpressing Human α-Synuclein.
    Gabrielyan L; Liang H; Minalyan A; Hatami A; John V; Wang L
    J Alzheimers Dis; 2021; 79(2):875-893. PubMed ID: 33361597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalization of human alpha-synuclein in the Thy1-aSyn ("Line 61") transgenic mouse line.
    Delenclos M; Carrascal L; Jensen K; Romero-Ramos M
    Neuroscience; 2014 Sep; 277():647-64. PubMed ID: 25090921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease.
    Magen I; Torres ER; Dinh D; Chung A; Masliah E; Chesselet MF
    J Parkinsons Dis; 2015; 5(3):669-680. PubMed ID: 25588356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
    Peneder TM; Scholze P; Berger ML; Reither H; Heinze G; Bertl J; Bauer J; Richfield EK; Hornykiewicz O; Pifl C
    Neuroscience; 2011 Apr; 180():280-92. PubMed ID: 21333719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.